Published in Auris Nasus Larynx on February 16, 2013
Testicular desmoplastic small round cell tumor: a case report and review of literature. World J Surg Oncol (2014) 0.77
An Update on Sinonasal Round Cell Undifferentiated Tumors. Head Neck Pathol (2016) 0.76
Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach. Curr Oncol Rep (2017) 0.75
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol (2010) 2.42
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood (2006) 1.57
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2007) 1.24
Squamous cell carcinoma of the external auditory canal. Skull Base (2008) 1.18
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13
Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck (2012) 1.13
Grisel's syndrome in head and neck practice. Oral Oncol (2005) 1.11
Retropharyngeal lymph node metastases in head and neck malignancies. Head Neck (2010) 1.09
Genomic profiling of sinonasal squamous cell carcinoma. Head Neck (2011) 1.08
Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo) (2012) 1.07
[Paranasal sinuses mucoceles. Our experience in 72 patients]. Acta Otorrinolaringol Esp (2009) 1.07
Comment on: Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in Pediatric Oncology. Pediatr Blood Cancer (2014) 1.07
Chondrosarcoma of the temporomandibular joint. A case report and review of the literature. Med Oral Patol Oral Cir Bucal (2009) 1.07
Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol (2004) 1.06
A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res (2009) 1.05
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Papillary cystadenoma and cystadenocarcinoma of salivary glands: two unusual entities. Med Oral Patol Oral Cir Bucal (2008) 1.04
Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck (2011) 1.04
Modern reconstruction techniques for oral and pharyngeal defects after tumor resection. Eur Arch Otorhinolaryngol (2007) 1.04
Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood (2003) 1.03
Temporal paragangliomas. Eur Arch Otorhinolaryngol (2007) 1.03
Mesenchymal chondrosarcoma of the head and neck. Oral Oncol (2007) 1.02
Is there an epidemiological link between human papillomavirus DNA and basaloid squamous cell carcinoma of the pharynx? Oral Oncol (2006) 1.01
Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review. Eur Arch Otorhinolaryngol (2008) 1.01
Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int J Cancer (2013) 1.01
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2012) 1.00
Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas. Mol Cancer (2010) 1.00
Primary treatment of the anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol (2006) 0.99
Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck (2011) 0.99
Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett (2008) 0.97
A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma. Blood (2010) 0.97
[Unusual clinical presentations of vestibular schwannomas]. Acta Otorrinolaringol Esp (2008) 0.97
Evolution of the management of laryngeal cancer. Oral Oncol (2006) 0.96
Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol (2003) 0.96
Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas. Nat Commun (2013) 0.96
Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck (2004) 0.96
Merkel cell carcinoma of the head and neck. Head Neck (2011) 0.96
Management of the N0 neck--reference or preference. Oral Oncol (2005) 0.95
When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol (2010) 0.94
Bilateral parotid basal cell adenoma: an unusual case report and review of the literature. J Oral Maxillofac Surg (2010) 0.94
Genetics of hereditary head and neck paragangliomas. Head Neck (2013) 0.94
Primary de novo intraosseous carcinoma: report of a new case. Med Oral Patol Oral Cir Bucal (2010) 0.93
KRAS and BRAF mutations in sinonasal cancer. Oral Oncol (2012) 0.92
Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas. Cell Oncol (2007) 0.92
Future of the TNM classification and staging system in head and neck cancer. Head Neck (2010) 0.92
Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications. J Mol Med (Berl) (2012) 0.91
Neuromonitoring of the laryngeal nerves in thyroid surgery: a critical appraisal of the literature. Eur Arch Otorhinolaryngol (2013) 0.91
Management of the orbit in malignant sinonasal tumors. Head Neck (2008) 0.90
New molecular diagnostic methods in head and neck cancer. Head Neck (2005) 0.90
Neck treatment and shoulder morbidity: still a challenge. Head Neck (2010) 0.90
Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol (2010) 0.89
Subtemporal-preauricular approach in the management of infratemporal and nasopharyngeal tumours. J Otolaryngol (2006) 0.89
Preliminary multi-institutional prospective pathologic and molecular studies support preservation of sublevel IIB and level IV for laryngeal squamous carcinoma with clinically negative neck. Eur Arch Otorhinolaryngol (2006) 0.89
Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. Brain Res (2003) 0.89
Comparative genomic hybridization in primary sinonasal adenocarcinomas. Cancer (2004) 0.88
P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer (2007) 0.88
Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type. Cell Oncol (Dordr) (2011) 0.88
EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas. Cell Oncol (Dordr) (2012) 0.87
Transoral laser surgery for supraglottic cancer. Head Neck (2008) 0.87
Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement. Clin Cancer Res (2004) 0.87
Clival chordomas: A pathological, surgical, and radiotherapeutic review. Head Neck (2013) 0.86
Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck (2008) 0.86
Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy. Cancer Prev Res (Phila) (2011) 0.86
Hepatocellular carcinoma metastatic to the mandible: a case involving severe hemorrhage. Med Oral (2004) 0.86
Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. Mod Pathol (2012) 0.86
Treatment considerations for head and neck cancer in the elderly. J Laryngol Otol (2005) 0.86
Idiopathic midline destructive disease: fact or fiction. Oral Oncol (2005) 0.86
Desmoid tumors of the head and neck: a therapeutic challenge. Head Neck (2014) 0.86
Complete spontaneous regression of Merkel cell carcinoma. Ann Otol Rhinol Laryngol (2005) 0.86
Screening for familial paragangliomas. Oral Oncol (2007) 0.86
Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary? Oral Oncol (2007) 0.86
Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma. Hum Pathol (2012) 0.85
Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. Oncol Rep (2009) 0.85
Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. Histopathology (2012) 0.85
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck (2006) 0.85
Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am J Rhinol (2005) 0.85
Causes of death of patients with laryngeal cancer. Eur Arch Otorhinolaryngol (2013) 0.85
Facial translocation approach in the management of central skull base and infratemporal tumors. Laryngoscope (2004) 0.85
Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions. Eur Arch Otorhinolaryngol (2011) 0.85
Merkel cell carcinoma: our experience in this rare pathology. Med Oral Patol Oral Cir Bucal (2011) 0.84
Minimally invasive treatment of the nasal inverted papilloma. Am J Rhinol (2004) 0.84
Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management. Cell Oncol (2010) 0.84
European surgeons were the first to perform neck dissection. Laryngoscope (2007) 0.83
[Surgical treatment of head and neck chondrosarcomas]. Acta Otorrinolaringol Esp (2010) 0.83
Prognostic factors of maxillary sinus malignancies. Am J Rhinol (2004) 0.83
Cutaneous cryptococcosis in a patient on chronic haemodialysis. Nefrologia (2012) 0.83
Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas. Hum Pathol (2010) 0.83
Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma. Acta Otolaryngol (2003) 0.83